Exact Mass: 520.2785
Exact Mass Matches: 520.2785
Found 126 metabolites which its exact mass value is equals to given mass value 520.2785
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Dolichol diphosphate
Nastorazepide
(3R,3aR,4S,11aR,13bS)-1,2,3,3a,4,5,9,11,11a,13b-decahydro-3a,11,11,13b-tetramethyl-3-{(1S)-1-[(2S)-3,6-dihydro-5-methyl-6-oxo-2H-pyran-2-yl]ethyl}-9-oxoindeo[5,4:4,5]cyclohepta[1,2-c]oxepin-4-yl acetate|heteroclitalactone G|polysperlactone A
(3R,9S)-megastigman-5-ene-3,9-diol 9-O-alpha-L-rhamnopyranosyl-(1?2)-beta-D-glucopyranoside|pteleifoside B
Phe Gln Ala Arg
Ala Phe Gln Arg
Ala Phe Arg Gln
Ala Gln Phe Arg
Ala Gln Arg Phe
Ala Arg Phe Gln
Ala Arg Gln Phe
Phe Ala Gln Arg
Phe Ala Arg Gln
Phe Gln Arg Ala
Phe Arg Ala Gln
Phe Arg Gln Ala
Lys Met Arg Ser
Lys Met Ser Arg
Lys Arg Met Ser
Lys Arg Ser Met
Lys Ser Met Arg
Lys Ser Arg Met
Met Lys Arg Ser
Met Lys Ser Arg
Met Arg Lys Ser
Met Arg Ser Lys
Met Ser Lys Arg
Met Ser Arg Lys
Gln Ala Phe Arg
Gln Ala Arg Phe
Gln Phe Ala Arg
Gln Phe Arg Ala
Gln Arg Ala Phe
Gln Arg Phe Ala
Arg Ala Phe Gln
Arg Ala Gln Phe
Arg Phe Ala Gln
Arg Phe Gln Ala
Arg Lys Met Ser
Arg Lys Ser Met
Arg Met Lys Ser
Arg Met Ser Lys
Arg Gln Ala Phe
Arg Gln Phe Ala
Arg Ser Lys Met
Arg Ser Met Lys
Ser Lys Met Arg
Ser Lys Arg Met
Ser Met Lys Arg
Ser Met Arg Lys
Ser Arg Lys Met
Ser Arg Met Lys
26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D2 / 26,26,26,27,27,27-hexafluoro-25-hydroxyergocalciferol
26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D2
26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D2
Gallopamil hydrochloride
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Nastorazepide
Nastorazepide (Z-360) is a selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity. Target:CCK-2 in vitro: Z-360 binds to the gastrin/CCK-2 receptor, thereby preventing receptor activation by gastrin, a peptide hormone frequently associated with the proliferation of gastrointestinal and pancreatic tumor cells. Check for active clinical trials or closed clinical trials using this agent. in vivo: Z-360 is a novel orally active CCK-2/gastrin receptor antagonist, significantly inhibits the growth of subcutaneous xenografts of human pancreatic tumor cells in mice, and that Z-360 combined with gemcitabine prolonged survival in a pancreatic carcinoma orthotopic xenograft mice.